Nurix Therapeutics, Inc. (NRIX) vs Stoke Therapeutics, Inc. (STOK)

• Nurix Therapeutics, Inc. NRIX 15.30 ▲ +3.10%
• Stoke Therapeutics, Inc. STOK 26.54 ▲ +1.80%

Nurix Therapeutics, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Nurix Therapeutics, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.7B and $1.6B). Stoke Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against −86.3%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −862.1%) and the higher return on invested capital (0.00% vs −482.0%). Across the 15 metrics below, Nurix Therapeutics, Inc. leads on 14 and Stoke Therapeutics, Inc. on 1.